Turnaround king? Daniel Greenleaf rolls up his sleevs
By Theresa Flaherty, Managing Editor
Updated Wed November 23, 2016
Daniel Greenleaf is in a familiar position. The new president and CEO of BioScrip is tasked with turning around an underperforming home infusion company, which he did with both Coram and, more recently, with Home Solutions.
“Under my leadership, my team and I developed and led transformational change resulting in Home Solutions becoming one of the top performing infusion services providers n the country,” said Greenleaf during a recent earnings call. “I see many similarities between the current state of BioScrip and the states of Coram and Home Solutions upon my arrival.”
Greenleaf has already identified his top five priorities: drive profitable growth; optimize operational efficiencies; create a predictable and consistent customer experience; enhance employee effectiveness; and exceed cash collection targets.
Enhancing employee effectiveness will play a key role: The company is now producing daily metrics and plans to increase not only employee accountability but also, the company's transparency, Greenleaf said.
“I've already seen many good people who are working hard and charging ahead with a real sense of urgency to assess processes and implement best practices across the board,” he said. “Things related to operations, management, sales, sense of urgency, focus and quality of people—those are in our control and can be fixed.”
Reducing staff, renegotiating supply chain arrangements and re-aligning the sales organization will improve margins, which will result in revenue growth, Greenleaf said.
Comments